# About Online Ipamorelin: An Independent Research Digest

> About Online Ipamorelin — an independent editorial project publishing plain-English, cited summaries of the peer-reviewed ipamorelin literature. Not a clinic, not a vendor.

An independent editorial project that reads the ipamorelin literature so it can be read clearly.

## What this site is

Online Ipamorelin is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on ipamorelin. We read the studies — the founding selectivity work, the human pharmacokinetics, the one Phase 2 trial, the animal record — and translate them into digests an ordinary, curious reader can follow without a pharmacology degree, while keeping every quantitative figure tied to its source.

We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

## About the name

The word "online" in this site's name describes where you are reading — a digest on the open web — not a storefront. Nothing here is for sale, and there is no order page, no price, and no supplier behind the name. We chose a forward-looking, optimistic register because ipamorelin's defining trait — a clean, selective growth-hormone pulse — is genuinely elegant pharmacology worth presenting with clarity rather than hype. Optimism about the science is not the same as a claim about its benefits, and we keep that line firm: where the human evidence is thin or negative, we say so plainly.

## How we handle the evidence

Three rules govern everything here. First, every quantitative claim — a dose, a half-life, an effect size — is cited to a real study listed on our [Ipamorelin references](/references) page. Second, we never present a human dosing recommendation; doses appear only as third-person study parameters. Third, we keep reported experience and measured evidence clearly separated: community reports are labeled anecdotal, and cited findings are labeled as findings. Ipamorelin is not an approved medicine, and this digest exists to document what the research actually shows — not to promote a compound or point anyone toward a product.

---

A forward-looking read of the ipamorelin literature, led by the one trait the molecule does cleanly — a selective GH pulse with the cortisol and prolactin left out — and honest about where the human evidence still runs thin; a reading instrument, not a clinic, a prescription, or a store.